ELAN CORP PLC (NYSE: ELN)

View Portfolio
Back to Investopedia
Back to Investopedia




$7.07 0.10 (1.43%)
Real-time 12:00:00 AM ET
 Turn On
KEY STATS
52-Week High Price
8.59
52-Week Low Price
4.61
Avg Volume (3 Mo.)
2.00 M
Market Cap
3.29 B
P/E Ratio (TTM)
63.4
Diluted EPS (TTM)
-0.54
Shares
471.41 M
Dividend Rate ($) / (%)
0.00/0.00
94%
6%
You need to upgrade your Flash Player to view the graph.
View by Date Range:
12 Mo. Price Change : -12% - ELN has underperformed the S&P 500 by 38%
SIMILAR COMPANIES
NameCurrent Price - Today's ChangeMarket Cap
PERRIGO CO (PRGO) $46.32 -  $0.58(1.27%)4.13 B
ALEXION PHARMACEUTICALS (ALXN) $46.91 -  $0.94(2.04%)4.14 B
WATSON PHARMACEUTICALS (WPI) $38.10 -  $0.41(1.09%)4.05 B
DR REDDY'S LAB LTD ADS (RDY) $23.66 -  $0.32(1.37%)4.07 B
DENDREON CORP (DNDN) $29.44 -  $0.55(1.90%)3.33 B
UNITED THERAPEUTICS CORP (UTHR) $58.63 -  $1.34(2.34%)3.07 B
IDEXX LABORATORIES INC (IDXX) $50.56 -  $0.57(1.14%)2.93 B
KING PHARMACEUTICALS INC (KG) $11.44 -  $0.14(1.24%)2.82 B
VALEANT PHARMACEUTICALS (VRX) $35.55 -  $1.06(3.07%)2.80 B
NBTY INC (NTY) $42.79 -  $0.28(0.65%)2.74 B
As of February 09, 2010 at 5:30 PM ET
STOCK ANALYSIS
Stock Analysis
Healthcare Earnings Are Coming Into Focus (ABC, MHS, DVA, ACOR, ELN)
Four names to watch in the healthcare space as their earnings are released Nov. 3.
Stock Analysis
Weak Dollar And Low Valuation To Boost J&J (JNJ, TEVA, ELN)
A couple of key investment merits should eventually allow J&J’s share price to increase markedly.
Stock Analysis
J&J Looks To Get Back On Track (JNJ, TEVA, MDT)
Investors are waiting for J&J to return to its heyday of double-digit growth.
Stock Analysis
High-Risk Acquisition The Right Prescription For Pfizer? (PFE)
Pfizer needs to refresh its pipeline, but taking on a high-risk/high-reward experimental drug could do more harm th...
Stock Analysis
Biotech Bulls For July 14 (NVS)
AS the economy slows, money often pours into healthcare, biotech and big pharma. This week focuses on Novartis AG ADS.
View All Stock Analysis
ELN RELATED HEADLINES
arrow
Next Up: The Boob Bomber
With airport security tightening, terrorists will have to hide explosives in their breast implants.
Forbes.com 1/5/2010
arrow
Elan Corp (ELN) NewsBite - ELN Halts Alzheimer's Treatment Trial
Elan Corp (NYSE: ELN) opened at $6.45. So far today, the stock has hit a low of $6.41 and a high of $6.59. ELN is now trading at $6.53, down $0.17 (-2.54%). Over the last 52 weeks the stock has ranged from a low of $4.61 to a high of $9.13. ELN announced this morning that it has ceased high-dose trials of its experimental Alzheimer's disease treatment after nine patients participating in the trial died....
At Market Intelligence Center 12/15/2009
arrow
Elan Corp (ELN) NewsBite - ELN Could Be On the Move
Elan Corp (ELN) could be on the move today and is now at $6.33, down $0.18 (-2.76%) on volume of 6,798,580 shares traded. Over the last 52 weeks the stock has ranged from a low of $4.61 to a high of $9.13. Elan Corp stock has been showing support around $6.09 and resistance in the $6.77 range. Technical indicator...
At Market Intelligence Center 11/10/2009
arrow
Healthcare Earnings Are Coming Into Focus (ABC, MHS, DVA, ACOR, ELN)
Four names to watch in the healthcare space as their earnings are released Nov. 3.
at Investopedia Advisor 10/30/2009
arrow
Elan Corp (ELN) NewsBite - ELN Downgraded By UBS
Elan Corp (ELN) was downgraded today by analysts at UBS and the stock is now at $5.12, up $0.10 (1.98%) on volume of 10,320,605 shares traded. UBS downgraded the stock today to Neutral, with the stock set a new 52 week low today. Over the last 52 weeks the stock has ranged from a low of $4.61 low today to a high of $9.13 in Janu...
At Market Intelligence Center 10/29/2009
arrow
Targeting Tysabri
The drug's inventor believes a new test might identify people who are less at risk for a deadly side effect.
Forbes.com 10/27/2009
View All Headlines
Stock Simulator- Free Account
Chart Advisor- Free Report
Sponsored Links
COLOSIM1